耐甲氧苄啶产气克雷伯菌 - Suppr | 超能文献

Trimethoprim-resistant Klebsiella aerogenes.

作者信息

McGill R E

出版信息

Lancet. 1978 Jul 15;2(8081):156. doi: 10.1016/s0140-6736(78)91541-6.

DOI:10.1016/s0140-6736(78)91541-6

PMID:78356

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Trimethoprim-resistant Klebsiella aerogenes.耐甲氧苄啶产气克雷伯菌

Lancet. 1978 Jul 15;2(8081):156. doi: 10.1016/s0140-6736(78)91541-6.

2

Multiple antibiotic resistance and capsular types of gentamicin-resistant Klebsiella aerogenes.

J Antimicrob Chemother. 1981 Mar;7(3):237-44. doi: 10.1093/jac/7.3.237.

3

Mutants of Klebsiella pneumoniae resistant to several antibiotics.

Nature. 1976 Jan 29;259(5541):307-8. doi: 10.1038/259307a0.

4

Prevention of emergence of bacterial resistance by combination of two antibiotics: rifampicin and trimethoprim.

J Antimicrob Chemother. 1980 May;6(3):349-56. doi: 10.1093/jac/6.3.349.

5

Antagonistic interaction of rifampicin and trimethoprim.

J Antimicrob Chemother. 1978 Jul;4(4):315-27. doi: 10.1093/jac/4.4.315.

6

A putative multi-replicon plasmid co-harboring beta-lactamase genes blaKPC-2, blaCTX-M-14 and blaTEM-1 and trimethoprim resistance gene dfrA25 from a Klebsiella pneumoniae sequence type (ST) 11 strain in China.在中国，一株肺炎克雷伯菌序列型（ST）11菌株中发现的一种假定的多复制子质粒，该质粒共携带β-内酰胺酶基因blaKPC-2、blaCTX-M-14和blaTEM-1以及甲氧苄啶抗性基因dfrA25。

PLoS One. 2017 Feb 2;12(2):e0171339. doi: 10.1371/journal.pone.0171339. eCollection 2017.

7

The in vitro demonstration of the efficacy of trimethoprim as an antibacterial agent in a comparative bacteriological study of the effects of trimethoprim, sulfamethoxazole and the combination trimethoprim-sulfamethoxazole.在一项关于甲氧苄啶、磺胺甲恶唑及甲氧苄啶-磺胺甲恶唑组合效果的比较细菌学研究中，对甲氧苄啶作为抗菌剂的疗效进行体外验证。

Chemotherapy. 1973;18(4):242-52. doi: 10.1159/000221268.

8

Cross-resistance to nalidixic acid, trimethoprim, and chloramphenicol associated with alterations in outer membrane proteins of Klebsiella, Enterobacter, and Serratia.与克雷伯菌属、肠杆菌属和沙雷菌属外膜蛋白改变相关的对萘啶酸、甲氧苄啶和氯霉素的交叉耐药性。

J Infect Dis. 1985 Mar;151(3):501-7. doi: 10.1093/infdis/151.3.501.

9

Klebsiella pneumoniae meningitis. Intravenous trimethoprim-sulfamethoxazole treatment.

JAMA. 1982 Sep 10;248(10):1212-3.

10

[Antibacterial activity in vitro and in vivo of the trimethoprim-sulphamethoxazole combination].甲氧苄啶-磺胺甲恶唑组合的体外和体内抗菌活性

Antibiotica. 1969 Dec;7(4):250-68.

引用本文的文献

1

Trimethoprim resistance in Finland after five years' use of plain trimethoprim.在单纯使用甲氧苄啶五年后芬兰出现的甲氧苄啶耐药性。

Br Med J. 1980 Jan 12;280(6207):72-4. doi: 10.1136/bmj.280.6207.72.

2

Resistance among fecal flora of patients taking sulfamethoxazole-trimethoprim or trimethoprim alone.服用复方磺胺甲恶唑或单独服用甲氧苄啶患者粪便菌群的耐药性。

Antimicrob Agents Chemother. 1981 Jan;19(1):33-8. doi: 10.1128/AAC.19.1.33.

3

Trimethoprim: a review of its antibacterial activity, pharmacokinetics and therapeutic use in urinary tract infections.甲氧苄啶：其抗菌活性、药代动力学及在尿路感染中的治疗应用综述

Drugs. 1982 Jun;23(6):405-30. doi: 10.2165/00003495-198223060-00001.